THE DEAL, AT A GLANCE
From the announcementLifeMine Therapeutics
01Who is involvedBacked by fungiFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedLifeMine Therapeutics raised $263M Series CFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersLifeMine Therapeutics has raised $263M to advance LIFE-001 and a broader transplantation and immunology pipeline, with the financing anchored by a $188M Series E…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
LifeMine Therapeutics · Financing Record
Explore source-linked visual explanations for LifeMine Therapeutics. Unsupported claims are withheld while source review continues.
Record 9838 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →